ECYT
Endocyte, Inc. Common Stock
ECYT
ECYT
Delisted
ECYT was delisted on the 20th of December, 2018.
71 hedge funds and large institutions have $86.1M invested in Endocyte, Inc. Common Stock in 2017 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 16 increasing their positions, 15 reducing their positions, and 17 closing their positions.
Holders
71
Holders Change
+8
Holders Change %
+12.7%
% of All Funds
1.61%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
25
Increased
16
Reduced
15
Closed
17
Calls
$737K
Puts
$1.79M
Net Calls
-$1.06M
Net Calls Change
-$622K
Top Buyers
1 |
PHS
1
PFM Health Sciences
San Francisco,
California
|
$14.7M |
2 |
RCM
2
RA Capital Management
Boston,
Massachusetts
|
$14.4M |
3 |
3
D.E. Shaw & Co
New York
|
$8.89M |
4 |
PA
4
Perceptive Advisors
New York
|
$6.21M |
5 |
BBA
5
Baker Bros. Advisors
New York
|
$4.65M |